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Abstract
The transcriptional repressors Snail and Slug are situated at the core of several signaling pathways proposed to mediate
epithelial to mesenchymal transition or EMT, which has been implicated in tumor metastasis. EMT involves an alteration from
an organized, epithelial cell structure to a mesenchymal, invasive and migratory phenotype. In order to obtain a global view of
the impact of Snail and Slug expression, we performed a microarray experiment using the MCF-7 breast cancer cell line, which
does not express detectable levels of Snail or Slug. MCF-7 cells were infected with Snail, Slug or control adenovirus, and RNA
samples isolated at various time points were analyzed across all transcripts. Our analyses indicated thatSnail and Slugregulate
many genesincommon,butalsohavedistinctsetsofgenetargets.GenesetenrichmentanalysesindicatedthatSnailand Slug
directed the transcriptome of MCF-7 cells from a luminal towards a more complex pattern that includes many features of the
claudin-low breast cancer signature. Of particular interest, genes involved in the TGF-beta signaling pathway are upregulated,
while genes responsible for a differentiated morphology are downregulated following Snail or Slug expression. Further we
noticed increased histone acetylation at the promoter region of the transforminggrowth factor beta-receptor II (TGFBR2) gene
following Snail or Slug expression. Inhibition of the TGF-beta signaling pathway using selective small-molecule inhibitors
following Snail or Slug addition resulted in decreased cell migration with no impact on the repression of cell junction
molecules by Snail and Slug. We propose that there are two regulatory modules embedded within EMT: one that involves
repression of cell junction molecules, and the other involving cell migration via TGF-beta and/or other pathways.
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Introduction
Breast cancer is the most frequently diagnosed malignancy in
women worldwide [reviewed in [1]]. In recent years, prognosis for
breast cancer has improved as a result of advances in diagnosis and
treatment. Nevertheless, tumor dormancy after treatment followed
by local, regional or distant recurrence is a leading cause of breast
cancer mortality [reviewed in [1]]. Clinically, advanced-stage
breast cancer is characterized by metastasis, a multi-step process
postulated to involve cancer cell invasion, proliferation, and
eventual survival in distant tissues following transport by the
circulatory system [1]. An early developmental phenomenon
known as ‘Epithelial to Mesenchymal Transition’ or EMT, which
results in the acquisition of an invasive, mesenchymal phenotype
by epithelial cells, has been postulated to play an important role in
cancer metastasis [reviewed in [2]]. Recently, cell-fate mapping
strategies in mouse models of mammary tumors [3] provided
direct evidence for EMT.
Several proteins that are involved in EMT during early
embryonic development have come under close scrutiny in cancer
cell programs. In particular, the role of the Snail family of zinc
finger proteins in EMT and cancer has been highlighted in several
publications [reviewed in [4]]. These proteins effect changes in
gene expression that are required for such important develop-
mental processes like mesoderm formation, left-right identity and
cell fate decisions [reviewed in [4]]. Responding to environmental
cues, the highly related transcriptional repressors Snail (SNAI1)
and Slug (SNAI2) are thought to act as master regulators, altering
expression of a number of genes including E-cadherin (CDH1)
[4,5,6], and contribute to physiological changes resulting in EMT
[4,7].
Despite the many similarities between Snail and Slug, there are
clear differences in their biological functions. Combinatorial
depletion of both factors by RNAi in an in vitro model of EMT
led to a more dramatic phenotypic alteration than modulation of
either factor alone [8]. Slug knockout mice can survive to
adulthood, while Snail knockout mice die at gastrulation [reviewed
in [4]]. Further, oncogene induction in an inducible mouse model
of mammary adenocarcinoma led to robust activation of Snail, but
not Slug, in the recurrent tumors that arose after withdrawal of
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Slug collaborate towards a similar goal of enhancing tumor growth
potential and induction of distant metastases, they might play
important but distinct roles at each stage of the tumor
dissemination process (i.e. migration, intravasation, transport to
a distant site, extravasation, or adaptation and growth of the
relocated cancer cells). These observations predict distinct roles for
Snail and Slug, and are compatible with current models
[10,11,12].
The TGF-beta family of signaling molecules has been
implicated in the upregulation of Snail [13,14] and Slug [15],
and also in EMT [16,17]. Additionally, TGF-beta dependent
activation of Snail and Slug is thought to be mutually exclusive
and context dependent [18]. The role of TGF-beta in cancer is
highly complex: this pathway functions both in tumor suppression
and in tumor promotion, and TGFBR2 is frequently inactivated in
breast cancer [ (reviewed in [19]], as it inhibits proliferation in
normal breast cells [reviewed in [19]. Absence of TGFBR2 and its
downstream targets, including the Smad transcription factors, has
been reported in different types of cancers [19,20]. However,
increased TGF-beta expression is positively correlated with breast
and other cancers, as well as invasive lymph node metastases in
breast cancer [10]. Smad3 and 4, downstream targets of TGFBR2,
collaborate with Snail in downregulation of E-cadherin [21]. The
TGF-beta pathway also induces Snail and Slug expression via the
Smad and HMGA2 proteins [22,23].
In this study, we examined the transcriptional consequences of
exogenous expression of Snail or Slug at the global level in a
luminal breast cancer cell line, MCF7. We observed downregu-
lation of transcripts integral to the luminal pattern of gene
expression observed in primary breast tumors [24,25]. In addition,
we found upregulation of genes characteristic of the basal and
claudin-low patterns [24,25]. Further, we demonstrated the
upregulation of TGF-beta signaling pathway members following
Snail and Slug expression. Pharmacologic blockade of TGF-beta
signaling decreased the migratory properties of cells following
Snail and Slug expression. Nevertheless, inhibition of TGF-beta
does not affect repression of cell junctional molecules by Snail and
Slug. We therefore propose that the EMT phenotype is a sum of at
least two distinct alterations: (a) changes in the transcriptional
program from a luminal to a more basal or claudin-low subtype
induced by transcription factors like Snail and Slug, and (b) a
morphologic change resulting in increased migration induced by
TGF-beta and other pathways.
Results
Snail and Slug regulate the expression of several genes in
common, but exhibit specificity in some of their gene
targets
To obtain a global view of the genome-wide impact of Snail or
Slug expression in a luminal breast cancer cell model (MCF-7), we
isolated RNA from MCF-7 cells 0,1, 2 and 4 days following
infection with control, Snail or Slug adenovirus (figures 1A and D)
and examined transcriptome changes using Affymetrix arrays.
After normalization, we filtered the data for genes with a two-fold
or higher change in expression (up or down) and an adjusted p-
value (false discovery rate) of 0.01 or lower. Using this filtered set
of genes, we observed alterations in steady state levels of many
transcripts following Snail or Slug expression relative to the day 0
and control adenovirus expressing cells (figure 1B and C). PCA
analysis (Figure S1) indicated that the replicates clustered together
with no outliers, and there were clear differences between the
control and Snail/Slug treatments for each day.
Relative to the control-infected cells, we found significant
changes in the levels of 975 genes following Snail expression, but
only 107 for Slug (Figure 1C and Table S1) after one day of
infection with the adenovirus. On day 2, Snail expression resulted
in downregulation of 1281 and upregulation of 377 genes, while
Slug expression on day 2 caused downregulation of 69 and
upregulation of 65 genes (Figure 1C and Table S1). By day 4,
Snail-treated cells had changes in the expression of 1559 genes in
total, and 1551 genes for Slug (Figure 1C and Table S1). In both
cases, there are more downregulated genes than upregulated,
which agrees with published literature arguing a repressive role for
these proteins [4]. At the earlier time points, Snail-treated samples
had more gene expression changes relative to Slug, but both
achieved similar gene expression profiles by day 4 (Figure 1B).
Immunoblotting analysis (Figure 1D) revealed that there were
similar levels of Snail and Slug protein expression; therefore, the
difference in the number of genes regulated by Snail and Slug at
earlier time points might reflect differences in binding affinity of
Snail and Slug, and/or the availability of cofactors. Snail and Slug
did not influence the expression of each other; therefore the
changes seen here are solely due to either Snail or Slug (Figure S2).
Many of the genes that changed in expression were common to
both Snail and Slug; however, as reported in other systems
[26,27], there were also unique categories regulated by Snail or
Slug (Figure 1C and Table S1). We validated some of the targets:
those that were previously described for their importance in
cancer, like CDH1 [6,28], OCLN [29] and ESR1 [30] (Figure 3B)
and some of the genes from our microarray analysis that were
differentially regulated by Snail and Slug (Figure S3). Among the
differentially expressed genes were ITGA2, EXPH5 and SGK3 for
Snail and G6PC3, TCF3 and SERPINE1 for Slug (Figure S3A and
B). We categorized the sets of genes that changed following Snail
and Slug expression for each time point using Ingenuity pathway
analysis (IPA) (File S1). As expected, genes involved in cell-cell
signaling and interaction, cell movement, development, growth
and proliferation, and cell death were among the top pathways
common to both Snail and Slug (File S1). The unique biological
pathways we found included p53 signaling, neuregulin signaling,
interferon signaling, and ERK5 signaling for Slug; and steroid and
glycosphingolipid biosynthesis, tight junction signaling and aryl
hydrocarbon receptor signaling for Snail (File S1). The transcrip-
tional signatures induced by both Snail and Slug suggest that each
of these transcription factors induces genes integral to migration,
invasion and metastasis, while the unique subsets of genes that are
changed may reflect subtle alterations in the biological program of
cancer cells reflective of signaling environment or other complex
biological parameters.
Snail and Slug decrease expression of differentiation-
specific genes that contribute to the breast epithelial
morphology while increasing TGF-beta family expression
Breast cancers have been classified into 5 molecular classes:
normal breast like, claudin-low, basal-like, Her2-enriched and
luminal [24,25]. MCF-7 cells closely resemble the luminal gene
expression pattern [25,31,32]. We asked whether the molecular
signature of MCF-7 cells changes following Snail and/or Slug
expression using GSEA, a computational method that assesses
whether an a priori defined set of genes shows statistically
significant, concordant differences between two biological states
[33]. We included gene sets representing claudin-low, basal, Her-
2, luminal and normal breast-like expression patterns within the
standard GSEA framework (see methods for details) [24]. Our
analyses revealed that the claudin-low signature was most enriched
and displayed the most significant global p-value relative to the
Snail and Slug Activate TGF-Beta
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These results demonstrate that the Snail and Slug expression in
MCF-7 cells alters the expression pattern from luminal to a more
complex pattern with features of the claudin-low subtype being
statistically enriched (Figure 2). Further, a large number of genes
with low-level expression in the claudin-low signature were
downregulated in Snail and Slug expressing cells (Figure 2)
consistent with their classification as transcriptional repressors.
Similar to the claudin-low category of breast tumors, the
CD44+ breast tumor cells also express low levels of differentiation
specific markers [34]. In addition, the CD44+ cells have high
levels of TGF-beta and stem cell genes [34]. To determine
whether Snail and Slug expression elicit a similar pattern, we
generated genesets representing the differentiated cell markers and
TGF-beta cassette as described by Polyak and colleagues, and used
it within the standard GSEA framework (see methods for details)
[34]. Indeed, the upper tier of significant molecular gene
signatures in our dataset using GSEA analysis included TGF-beta
pathway genes (upregulated) and differentiation specific genes
(downregulated) (Table 1 and Figure 3A and C).
Next, we validated key genes revealed in the enrichment
analysis by real-time RT-PCR. Both Snail and Slug expression in
MCF-7 cells caused decreased expression of differentiation specific
markers (Figure 3A and B) including ESR1, OCLN and CDH1
[5,28,29,30,35]. Importantly, these genes contain putative Snail
and/or Slug binding sites in their 59 regions and have been
previously shown to be direct targets of Snail and/or Slug
[6,30,36]. In addition, TGF-beta pathway genes were upregulated
following Snail and Slug expression (Figure 3C–E). Among these,
SPARC (secreted protein, acidic, cysteine-rich) is a matrix-
associated protein that influences changes in cell shape and
synthesis of the extracellular matrix, and inhibits cell-cycle
progression [37]. SPARC has been identified as a putative target
of Snail and Slug [38], as well as TGF-beta [39]. Connective tissue
growth factor (CTGF) has been reported to be selectively
upregulated in fibroblasts following activation by TGF-beta
[40,41,42]. It has been suggested that CTGF along with Interleukin
11 might influence cancer metastasis to the bone in breast cancer
[43]. Transgelin, an actin-binding protein sensitive to changes in
cell shape, is thought to be involved in cell migration [44], and is a
direct downstream target of TGF-beta signaling [44]. Collectively
our data indicate that expression of several genes in the TGF-beta
family is upregulated following Snail and Slug expression.
Increased histone acetylation at TGFBR2 locus following
Snail and Slug expression
The presence of TGFBR2 among genes upregulated following
Snail and Slug expression was intriguing, as the TGF-beta
signaling pathway is upstream of Snail and Slug and induces
their expression [14,45,46]. MCF-7 cells do not express much
TGFBR2 mRNA relative to MDA-MB-231 (Figure S5). We
utilized chromatin immunoprecipitation (ChIP) to examine the
Figure 1. Snail and Slug regulate common and unique sets of genes in breast cancer cells. A) Schematic representation of microarray
experiment. B) Heat map depicting probes with absolute fold .2 and adjusted p-value,0.01 on Day4 after Snail and Slug expression, shown over
time. C) Venn diagrams showing the total number of genes that change following Snail or Slug expression, with absolute fold .2 and adjusted p-
value,0.01. D) Immunoblots showing the expression of Snail, Slug or Actin in MCF-7 (untreated) and following 2–4 days of adenovirus expression.
doi:10.1371/journal.pone.0026514.g001
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(Figure 4A) in MDA-MB-231 and MCF-7 cells (Figure 4B and
C), using antibodies against acetylated Histone H3 Lysine 9
(H3K9Ac), which is associated with active chromatin, and
trimethylated Histone H3 Lysine 9 (H3K9Me3), which is found
in conjunction with silent chromatin [47]. While we observed
neither significant acetylation nor trimethylation of histone H3K9
across the TGFBR2 promoter in MCF-7 cells (Figure 4B), there
was a substantial level of H3K9 acetylation across the promoter in
MDA-MB-231 cells where the gene is active (Figure 4C). The
highest degree of acetylation at TGFBR2 in MDA-MB-231 cells is
found in the vicinity of primer set 3, which maps near the end of
the first exon (Figure 4A and C).
To determine whether the addition of Snail and Slug enables a
more ‘open’ chromatin status at the TGFBR2 promoter, we
performed ChIP in MCF-7 cells following two days of Snail and
Slug expression. Relative to control-treated cells, we saw an
increase in H3K9 acetylation in Snail and Slug expressing MCF-7
cells (Figure 4 D–F) in a pattern similar to MDA-MB-231 cells,
with the highest level around primer set 3. The level of acetylation
following Snail or Slug expression is higher than in MCF-7 cells,
but not as much as MDA-MB-231 cells (compare Figure 4C to 4E
and F). To our knowledge, this is the first demonstration that
addition of Snail and Slug can increase histone acetylation status
of theTGFBR2 promoter.
Treatment with inhibitors of TGF-beta signaling reduces
cell migration ability in response to Snail and Slug
Both TGF-beta signaling and Snail (or Slug) are known to
induce EMT [14,45,46]. TGF-beta is also known to induce Snail
and Slug expression, and our studies indicate that Snail and Slug
can induce TGF-beta pathway genes. Therefore, we enquired
whether we could mechanistically dissect the effects of Snail (or
Slug) and TGF-beta in inducing EMT. To this end, we treated
MCF-7 cells with control, Snail or Slug adenovirus, and either
DMSO or one of two small molecule inhibitors: SB431542, a
highly specific inhibitor of TGFBR2 [48], and LY364947, which
inhibits both TGFBR1, and to a lesser degree, TGFBR2 [49].
After two days of treatment with the virus and inhibitors or
DMSO as vehicle control, we determined whether inhibiting the
TGF beta pathway influenced the cell migration ability induced
by Snail and Slug. We used a Boyden chamber assay to evaluate
cell migration through a membrane coated with human
Collagen IV.
Figure 2. Snail and Slug cause changes in expression that most
resemble the claudin-low class of breast tumors. GSEA analysis
(A) comparing the genes in the microarray samples to those that were
upregulated (B and C, top panels) or downregulated (B and C, bottom
panels) from the claudin-low class (B) and luminal class (C) described in
[24]. See text for details. NES=Normalized enrichment score, GPV=Glo-
bal p-value.
doi:10.1371/journal.pone.0026514.g002
Table 1. GSEA analysis.
TGF-beta family markers Differentiated Cell Markers
Signatures
Normalized Enrichment
Score (NES)
False
Discovery Rate
Global
p-value (GPV)
Normalized Enrichment
Score (NES)
False
Discovery Rate
Global
p-value (GPV)
Snail Day 1 2.31 0.001 0.000006 22.68 0.001 0.000023
Snail Day 2 2.59 0.001 0.000011 22.59 0.001 0.000025
Snail Day 4 2.93 0.001 0.000005 22.32 0.001 0.000063
Slug Day 1 2.69 0.001 0.000004 22.34 0.001 0.000017
Slug Day 2 2.71 0.001 0.000004 21.79 0.010 0.001320
Slug Day 4 2.48 0.001 0.000015 22.35 0.001 0.000038
GSEA was performed using genesets consisting of differentiated cell markers and the TGF-beta genes described in [34]. The global p-value represents the tail probability
from a density plot of normalized enrichment score values across all genesets and all permutations.
doi:10.1371/journal.pone.0026514.t001
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migratory (Figure 5A). However, treatment with the inhibitors
caused a decrease in the cell migration ability of MDA-MB-231
(Figure 5A). When we treated MCF-7 cells with the control
adenovirus, it behaved similar to the MCF-7 cells without
adenovirus treatment (Figure 5A). Addition of Snail or Slug
increased the migration of MCF-7 by roughly three-fold relative to
the control cells, while inhibition of TGF-beta signaling diminishes
this response down to background levels (Figure 5A).
Components of the junctional complexes that join epithelial
cells have been proposed to act as kinetic barriers to migratory and
invasive growth in cancer [5,50]. As the inhibitors employed here
block acquisition of these properties, we asked whether they also
impact repression of junctional complex components. Real-time
PCR analysis of gene expression revealed that representative
components of the adherens junction (E-cadherin), desmosome
(Desmoplakin) or tight junctions (Claudin 4) were still repressed by
Snail, despite the addition of TGF-beta inhibitors (Figure 5B).
Thus, inhibition of the TGF-beta signaling pathway caused a
decrease in cell migration that was not due to repression of cell
junctional molecules by Snail.
Discussion
EMT offers an attractive model to explain how epithelial cancer
cells can change phenotype rapidly (yet reversibly) and migrate,
leading to cancer metastasis [7]. The transcriptional repressors
Snail and Slug are sufficient to induce EMT when expressed in
epithelial systems [7], and so is triggering the TGF-beta signaling
pathway [17], which can also stimulate Snail and Slug expression
[14,15,46]. Here, we showed that Snail and Slug could in turn
increase expression of the TGF-beta pathway members in a
positive feedback mechanism, resulting in increased migratory
properties of the cell. Further, we mechanistically dissected the
roles for Snail and TGF-beta in eliciting EMT.
Snail and Slug decrease the expression of differentiation-
specific genes
Global gene expression profiling of normal and cancerous
breast tissues have resulted in the molecular classification of breast
cancer into luminal, basal, Her-2 enriched, claudin-low and
normal breast-like groups [25]. These categories have been useful
in predicting clinical parameters of disease including survival and
Figure 3. Snail and Slug expression in MCF-7 cells decreases the expression of differentiation markers, and increases the
expression of TGF-beta pathway genes. Heat maps depicting (A) differentiated cell markers (C) TGF-b pathway probes following Snail and Slug
expression. (B, D and E) RT-PCR of cDNA with real-time quantitation following normalization to 18 s, MCF-7 Day 0 and control adenovirus. The data
represents the average of three independent biological replicates.
doi:10.1371/journal.pone.0026514.g003
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class, which is non-invasive, highly differentiated and positive for
ER (Estrogen receptor) and PR (Progesterone receptor). Using
GSEA, we found changes in a number of gene sets representing
different breast cancer subtypes with significant p-values. Howev-
er, when we performed GSEA by comparing the Control-treated
cells to Snail and Slug treated cells, the Claudin-low gene set
exhibited the most significant global p-value and the significantly
large NES compared to all other cancer subtypes (Figures 2 and
S4). These results indicate that the transformation in the
transcriptome of MCF7 cells triggered by Snail/Slug expression,
while complex, most closely resembles the claudin-low type
(Figure 2). Snail and Slug expression in MCF-7 resulted in
decreased expression of differentiation- specific molecules that
make up the luminal A phenotype, and an increased claudin-low
gene expression signature (Figures 2 and 3), which is triple
negative (ER, PR and HER2 negative), highly invasive, and
enriched with progenitor cell markers and a core EMT signature
[51]. This is consistent with the model that indicates a close
relationship between EMT and a CD44hi/CD24 lo/- stem cell
phenotype (3, 50). Several genes in the basal class were also
similarly up or downregulated following Snail and Slug expression,
whereas the overlap was much less with genes in the HER2 class
(Figure S4). Overall, this indicates that Snail and Slug drive the
transcriptome profile of MCF-7 cells from a luminal towards a
claudin-low/basal phenotype, which is associated with poorer
prognosis in the clinic [24,32].
Snail and Slug expression upregulates TGF-beta pathway
markers
Breast cells with a CD44
+/CD24
2/lo phenotype show increased
expression of the ‘TGF-beta cassette’ group of genes and
progenitor markers [34]. Following Snail and Slug expression,
we also observed a strong upregulation of the TGF-beta pathway
markers (Figure 3C–E). Specifically, there was an increase in
CTGF, SPARC, TAGLN, TGFB2 and TGFBR2 (Figure 3C–E),
which are important in the TGF-beta signaling pathway
[19,20,39,40,42,44]. The transforming growth factor beta family
of receptors is evolutionarily highly conserved, and is hypothesized
to play a dual role in cancer progression [20], both as a tumor-
suppressor in the normal mammary gland [19], and tumor
promoter in mouse models [52] and others.
Our data imply that Snail and Slug upregulated TGFBR2
expression (Figure 3), and this was accompanied by elevated levels
of histone H3K9 acetylation (Figure 4), a mark that is associated
with transcriptionally active chromatin [47] across the promoter
Figure 4. TGFBR2 shows distinct histone acetylation patterns in MCF7 and MDA231, and this changes upon addition of Snail and
Slug. Primers for ChIP were designed across the TGFBR2 promoter region (A). Chromatin IP across the TGFBR2 promoter in MDA-MB-231 (C)
demonstrated an increased amount of histone H3K9 acetylation compared to MCF-7 cells (B). Increased acetylation is also seen when Snail or Slug are
expressed in MCF-7 cells (E and F), relative to the control-adenovirus infected cells (D). The data is representative of three independent biological
replicates.
doi:10.1371/journal.pone.0026514.g004
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indirectly induce TGFBR2 transcription remains to be studied.
Snail and Slug induce an EMT phenotype at least in part
through the action of TGF-beta signaling
The EMT-like phenotype induced by Snail and Slug appears to
consist of two complementary processes: upregulation of TGF-
beta and early progenitor cell markers, and a downregulation of
the cell-cell adhesion and differentiation specific markers. The
resulting so-called ‘metastable’ phenotype [7] results in a cell that
is highly motile, resistant to apoptosis and has decreased cell-cell
adhesion, all of which are important in achieving cell migration.
These processes have been previously shown to be stimulated by
both Snail and Slug, as well as by TGF-beta signaling. TGF-beta
itself influences the actions of Snail by both increasing expression
[14,22] and promoting Snail binding at target promoters through
the coactivator Smads [21]. Our data indicated that Snail and
Slug can in turn upregulate the TGF-beta pathway genes
(Figure 3C–E).
We attempted to mechanistically separate the actions of Snail/
Slug and TGF-beta in inducing EMT by treating MCF-7 cells
concurrently with Snail, Slug or control adenovirus and small
molecule inhibitors that interfered with the TGF-beta signaling
pathway (Figure 5A). Our experiments indicated that while Snail
or Slug by themselves caused a roughly three-fold increase in cell
migration relative to the control cells, inhibition of TGF-beta
signaling diminished this response to near background levels
(Figure 5A). However, cell junctional components are still
repressed by Snail expression, despite inhibition of the TGF-beta
pathway (Figure 5 B). This is reminiscent of other studies [53,54]
that proposed two components of EMT: a morphologic branch
and a gene expression branch. Here, inhibition of TGF-beta does
not appear to affect the gene repression induced by Snail (Figure 5
B); however, the ability of cells to migrate is affected (Figure 5 A).
This could potentially occur through the TGF-beta- Par6 polarity
pathway [53,54], but further studies are needed to test this. We
suggest that there are two branches of the EMT phenotype: one
that involves the transcription program, i.e. repression of cell
junction molecules by Snail or Slug, and the other involving cell
migration via TGF-beta and/or other pathways.
Snail, Slug and EMT in breast tumors
EMT remains a highly controversial subject, with many
pathologists rejecting the idea of a ‘transition’ in human breast
tumors, while proponents of EMT have devised clever ways to
demonstrate the phenomenon in mouse models [reviewed in [7]].
Whatever the case, there is no doubt that Snail and Slug remain
positively correlated with highly migratory cells, both in the clinic
and the laboratory [7,10]. Thus, we can conceive of a model
wherein epigenetic and/or environmental factors can trigger the
expression of Snail and/or Slug in rapidly proliferating, differen-
tiated tumor cells, resulting in (a) repression of differentiation
specific genes and (b) activation of TGF-beta pathway and
progenitor cell markers, leading to increased migration (Figure 6).
The end result is a claudin-low phenotype, which is associated
with highly invasive cancers that have a poor prognosis [24].
Anti-estrogenic compounds like tamoxifen, which target estro-
gen receptor signaling, are widely used for treating breast cancer in
the clinic [2]. While this has proved effective in reducing tumor
cell proliferation, loss of estrogen receptor signaling can inadver-
tently increase Snail and TGF-beta signaling [30], resulting in
increased cell migration and metastasis. Indeed, some breast
tumors develop resistance to anti-estrogenic treatment. Our results
suggest that the cell migration induced by Snail or Slug expression
could be checked by addition of TGF-beta signaling inhibitors
(Figure 5A). Therefore, the sequential treatments with estrogenic
Figure 5. Treatment with a TGF-beta inhibitor reduces the migratory response to Snail and Slug. (A) Cell migration assay using MDA-MB-
231, uninfected MCF-7 cells, and MCF-7 cells infected with control, Snail or Slug adenoviruses (white bars), treated with DMSO (light grey bars) or with
10 mM final of the TGF-beta inhibitors LY364947 (dark grey bars) or SB431542 (black bars) for 2 days. The X-axis represents the total number of cells in
10 fields. The data represents the average of three independent biological replicates (* T-test p-value #0.05, **T-test p-value #0.01). (B) Addition of
TGF-beta inhibitor does not affect repression of cell junction molecules CDH1, DSP and CLDN4. MCF-7 cells were untreated or treated with control or
Snail adenovirus, and with DMSO vehicle or SB431542 for 2 days. RNA was isolated and RT-PCR of cDNA with real-time quantitation was performed
following normalization to GAPDH, and MCF-7 Day 0. The data represents the average of three independent biological replicates.
doi:10.1371/journal.pone.0026514.g005
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Materials and Methods
Cell culture and adenovirus methods
Human breast carcinoma cell lines MCF-7 and MDA-MB-231
were obtained from the American Type Culture Collection
(Manassas, VA) and cultured in DMEM/F-12 medium supple-
mented with 10% FBS at 37 degrees C in 5% CO2. Adenoviruses
were prepared as described previously [35].
RNA isolation, microarray methodology and data analysis
Following 0,1,2 and 4 days of infection with Snail, Slug or
control (GFP-only) adenovirus, RNA was isolated from MCF-7
cells using Trizol (Invitrogen), cleaned through Qiagen columns
and resuspended in DEPC-treated water. The RNA was checked
for quality and processed using standard hybridization protocols
for Affymetrix Human Genome U133 Plus 2.0 GeneChipH
arrays (Affymetrix, Santa Clara, CA). Arrays were scanned with
the Affymetrix Scanner 3000 and data obtained using Gene-
ChipH Operating Software (GCOS; Version 1.4.0.036). The .cel
files were background corrected and normalized using Robust
Multi-array Average (RMA) method [55]. Principal Component
Analysis (PCA) was performed on the background corrected and
normalized data, for all probes and samples using the
programming language R (www.r-package.org) to characterize
the variability present in the data. In order to identify
differentially expressed probes, one-way analysis of variance
(ANOVA) was used to determine if there was a statistical
difference between the means of the untreated, control adeno-
virus-treated, and Snail or Slug adenovirus-treated groups at each
time point. The resulting p-values were adjusted for multiple
testing using the Benjamini Hochberg method (false discovery
rate) [56]. Probes were ranked based on their adjusted p-values
and fold change. Probes that displayed a fold change of two-fold
or greater in either direction, along with adjusted p-values less
than 0.01 were selected for further analysis. An unsupervised
hierarchical clustering of samples based on the differentially
expressed probes at day 4 using the normalized data and average
linkage clustering resulted in a clear separation between the Snail
or Slug samples compared to controls. The microarray data is
available at the GEO database (http://www.ncbi.nlm.nih.gov/
geo/query/acc.cgi), accession code GSE29672. All our data is
MIAME compliant.
GSEA analysis
Gene set enrichment analysis (GSEA) is a computational
method that determines whether an a priori defined set of
genes (referred as ‘gene sets’) shows statistically significant,
concordant differences between two biological states (e.g.
phenotypes). To perform such functional analysis of micro-
array data, the GSEA utilizes thousands of annotated gene sets
hosted within the Molecular Signatures Database (MSigDB).
In this study, GSEA [33] was performed using the gene sets
a v a i l a b l ei nt h eM S i g D Bv 3 . 0 ,w i t ha na d d i t i o n a l1 2g e n es e t s
added to the MSigDB. Specifically, we added 10 genesets
corresponding to 5 molecular breast cancer signatures (up/
down regulated in Basal, Claudin-low, Normal-like, Her2 and
Luminal) [24], where the signatures comprised of genes with
2.5 or greater fold change in a particular breast cell type
compared to all the rest [24]. In addition, we generated 2
genesets using the genes that comprise the differentiated cell
markers and TGF-beta cassette described in [34]. We
performed GSEA by comparing gene expression profile of
Snail/Slug to Control at each day (day 1, 2 and 4). Gene sets
were ranked by their global p-value. The global p-value
represents the tail probability from a density plot of normalized
enrichment score values across all gene sets and all permuta-
tions. The geneset enrichment statistics was derived using the
probe-level signal-to-noise ratio measurements. The signifi-
cance test of geneset enrichment statistic was performed using
1000 random probe/sample permutations. The normalized
enrichment scores across all genesets and all permutations
were used to compute false discovery rate and global p-value..
We generated heat maps to visualize the expression differences
in Snail, Slug and controls for the set of genes mentioned
above.
Real-Time PCR validation
We performed RT-PCR using the same RNA that was utilized
in the microarray analysis. To quantify nascent RNA, RT-PCR
with real-time quantitation was performed using an iCycler system
(Bio-Rad) as previously described [35]. RT-PCR primer sets for
ESR1, XBP1, CDH1, OCNL, DSP, GATA3, TGFB2, TGFBR2, FN1
and 18S were obtained from Qiagen (Quantitect primers). Primer
DNA sequences for TAGLN, SPARC, CTGF and CLDN7 are listed
in Table S2.
Figure 6. A role for Snail and Slug in upregulating TGF-beta
during EMT. In normal breast cells, the TGF-beta pathway is active in
keeping Estrogen receptor-alpha cells from proliferating. A) In cancer
cells with a luminal phenotype (e.g. MCF-7), the TGF-beta pathway is
downregulated, ER-alpha and MTA3 are expressed, and Snail expression
is inhibited. This results in a differentiated and epithelial phenotype
with well-preserved cell junctions, and the cells are adherent and non-
migratory. B) During EMT, expression of Snail (and/or Slug) causes
downregulation of ER-alpha and upregulation of the TGF-beta pathway.
However, TGF-beta now serves a pro-metastatic role, and early
progenitor markers are induced, resulting in a more ‘claudin-low’
morphology that is more mesenchymal and highly migratory.
doi:10.1371/journal.pone.0026514.g006
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Antibodies utilized included Snail (Abcam; ab17732) and Actin
(Chemicon; MAB1501). Immunoblotting was performed using
standard protocols.
Chromatin Immunoprecipitation Analysis (ChIP)
Chromatin Immunoprecipitation was performed as previously
described (Dhasarathy et al., 2007) using antibodies against Histone
H3K9 acetyl (Upstate 07-352) and Histone H3K9 trimethyl (Abcam
ab8898-100). Precipitated DNAs were detected by real time PCR
using specific primers for the TGFBR2 promoter (Table S2).
Cell migration assay
The inhibitors were obtained from Sigma. Boyden chambers
were prepared with the lower chamber containing DMEM/F-12
media with 10% fetal bovine serum (FBS) as chemoattractant and
overlaid with nucleopore track-etch membranes (Whatman,
13 mm diameter, 8 mm pore size) coated with Human Collagen
IV (BD Biosciences, 354245). MCF-7 cells treated with or without
adenovirus and with or without inhibitors [SB431542 (Sigma,
S4317) or LY364947 (Sigma, L6293)] or DMSO for 2 days, were
resuspended in media without FBS and 20,000 cells placed in the
upper chamber on the coated membrane. After 24 hours of
incubation in a 37uCC O 2 incubator, the non-migratory cells on
the membrane surface were removed. The membranes (with
migrated cells on the other side) were fixed with 4% formaldehyde,
stained with 0.5% Crystal violet and mounted on glass slides. Ten
fields were counted using a 56 lens on a Zeiss Axiovert 200 M
microscope (Zeiss Microimaging Inc.).
Supporting Information
Figure S1 PCA analysis. Principal Component Analysis (PCA)
was performed on the background corrected and normalized data,
for all probes and all samples as implemented in the programming
language R (www.r-package.org). We used unsupervised hierar-
chical clustering of samples based on the differentially expressed
probes at day 4 using the normalized data and average linkage
clustering. This analysis revealed clear separation between the
Snail and Slug treated MCF-7 samples relative to control.
PC#1=first principal component, PC#2=second principal
component, PC#3=third principal component.
(TIF)
Figure S2 Snail and Slug do not influence the expression
of each other in MCF-7 cells. The expression of Snail (A) and
Slug (B) was examined in MCF-7 cells 2 and 4 days after addition
of Snail or Slug adenovirus, using RT-PCR of cDNA with real-
time quantitation following normalization to GAPDH, MCF-7
Day 0 and control adenovirus. The data represents the average of
three independent biological replicates.
(TIF)
Figure S3 RT-PCR validation of genes that are uniquely
regulated by Snail and Slug. cDNA was prepared from the
same RNA that was used in the microarray experiment, and RT-
PCR with real-time quantitation was performed using an iCycler
system (Bio-Rad) to measure the RNA fold change following
normalization to 18 s, MCF-7 Day 0 and control adenovirus. (A)
RT-PCR validation of genes that change in Snail- but not Slug-
expressing cells and (B) RT-PCR validation of genes that change
in Slug- but not Snail-expressing cells.
(TIF)
Figure S4 GSEA analysis following Snail and Slug
expression. GSEA analysis comparing the genes that were
upregulated (A, C and E) or downregulated (B, D and F) in our
microarray samples to those from the normal breast class (A and
B), Her2-positive (C and D) and basal (E and F) categories of
breast tumors described in [24].
(TIF)
Figure S5 Relative RNA levels of TGF-beta markers in
MCF-7 and MDA-MB-231 cells. Relative to MCF-7, the
highly invasive cell line MDA-MB-231 shows increased expression
of FN1, TGFB2, TGFBR2, CTGF and SPARC, but not TGFB1.
RNA was isolated from MCF-7 and MDA-MB-231 cells, cDNA
was prepared and RT-PCR with real-time quantitation was
performed using an iCycler system (Bio-Rad) to measure the RNA
fold change following normalization to 18 s. The data represents
the average of three independent biological replicates.
(TIF)
File S1 IPA analysis. We obtained the genes list for each of
the following comparisons using the criteria: absolute (fold).2
and adjusted pvalue,0 . 0 1 :S n a i lD a y1V s .M o c kD a y1 ,S n a i l
Day 2 Vs. Mock Day 2, Snail Day 4 Vs. Mock Day 4, Slug Day
1V s .M o c kD a y1 ,S l u gD a y2V s .M o c kD a y2a n dS l u gD a y4
Vs. Mock Day 4. We used the gene list described above as in
input to find significantly enriched canonical pathways for each
of the six comparisons by employing Ingenuity Pathway
Analysis (IPA) software (www.ingenuity.com). Genes that are
associated with a canonical pathway in the Ingenuity Knowl-
edge Base were considered for the analysis. The significance of
the association between the data set and the canonical pathway
was measured in 2 ways: 1) A ratio of the number of genes from
the data set that map to the pathway divided by the total
number of genes that map to the canonical pathway, and 2)
Fisher’s exact test was used to calculate a p-value determining
the probability that the association between the genes in the
dataset and the canonical pathway is explained by chance alone
(File S1).
(PDF)
Table S1 Microarray genes changing over time with
fold change.2, p-value,0.01 (adjusted), following Snail
and Slug expression. Probes that displayed a fold change of
two-fold or greater in either direction, along with adjusted p-values
less than 0.01 following Snail and Slug expression.
(PDF)
Table S2 List of primers used in study.
(PDF)
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